Trinity Biotech (TRIB) Reports Q4 Loss of $0.23/sh

Trinity Biotech (NASDAQ: TRIB) reported Q4 EPS of ($0.23), versus $0.60 reported last year. Revenue for the quarter came in at $19.5 million versus the consensus estimate of $22 million.

For earnings history and earnings-related data on Trinity Biotech (TRIB) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• FDA approves Padcev plus Keytruda for muscle-invasive bladder cancer
• UBS Reiterates Buy Rating on Dollar Tree (DLTR)